Stroke and Anxiety Reduction

NYU Langone Health

Status: Completed

Conditions: Acute Stroke

Treatments: Behavioral: Anxiety Reduction Bundle

Study type: Interventional

Funder types: Other

Identifiers

NCT06013982

23-00759

Details and patient eligibility

About

The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medical center. Eligible participants will be screened and recruited by the research team through daily rounds. After completing the informed consent process, the research team will pull demographic information from the electronic health record (EHR) and REDCAP that includes ethnicity and support system. Participants will complete the Anxiety Screen Questionnaire (GAD-7 ANXIETY SURVEY) and will be provided with information regarding stroke support groups available with additional NYU Langone Health and the American Heart Association internet-based information regarding anxiety reduction (NYU Langone Health Anxiety Reduction Bundle). The participants will be encouraged to attend a stroke support group for 3 months and utilize the NYU Langone Health Anxiety Reduction Bundle provided. At the completion of the intervention (3 months), participants will be provided with the GAD-7 ANXIETY SURVEY again and a survey that includes open-ended questions and a program evaluation by email. Analysis will occur after final data is collected.

Enrollment: 34 patients

Sex: All

Ages: 18 to 89 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be diagnosed with an acute stroke
• Able to speak, read and write in English
• Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
• Discharged to home
• Internet access including email
• Willingness to participate in an anxiety reduction program
• Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
• Must be medically stable

Exclusion criteria

• Not diagnosed with an acute stroke
• Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
• Not discharged to home
• No internet access including email
• Unwilling or unable to participate in an anxiety reduction program
• Cognitively impaired
• Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
• Not medically stable

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

34 participants in 1 patient group

Patients discharged following acute care stroke

Experimental group

Description:

Participation will last 3 months from enrollment. Demographic data will be retrieved from the electronic health record and the Generalized Anxiety Disorder-7 (GAD-7) Anxiety Questionnaire will be administered at baseline. Participants will repeat the GAD-7 in 3 months and an additional qualitative survey on their experience including an evaluation of the structured anxiety reduction program.

Treatment:

Behavioral: Anxiety Reduction Bundle